RHUMBLINE ADVISERS - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 62 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$537
-99.9%
606,023
+8.7%
0.00%0.0%
Q3 2022$875,000
-16.7%
557,591
+6.6%
0.00%
-50.0%
Q2 2022$1,051,000
+45.6%
522,863
+68.8%
0.00%
+100.0%
Q1 2022$722,000
-49.0%
309,702
+1.7%
0.00%
-50.0%
Q4 2021$1,415,000
-37.9%
304,405
+1.9%
0.00%
-33.3%
Q3 2021$2,279,000
-19.3%
298,752
+2.5%
0.00%
-25.0%
Q2 2021$2,824,000
+20.9%
291,417
+3.2%
0.00%
+33.3%
Q1 2021$2,336,000
+16.4%
282,514
-3.9%
0.00%0.0%
Q4 2020$2,007,000
-27.8%
294,032
+18.0%
0.00%
-25.0%
Q3 2020$2,778,000
+68.1%
249,179
-5.3%
0.00%
+33.3%
Q2 2020$1,653,000
+451.0%
263,261
+61.5%
0.00%
+200.0%
Q1 2020$300,000
-45.8%
162,965
-0.5%
0.00%0.0%
Q4 2019$554,000
+64.9%
163,774
+4.5%
0.00%0.0%
Q3 2019$336,000
-19.2%
156,776
+0.7%
0.00%0.0%
Q2 2019$416,000
-37.2%
155,636
+11.6%
0.00%0.0%
Q1 2019$662,000
+100.6%
139,448
+1.3%
0.00%0.0%
Q4 2018$330,000
-10.3%
137,637
+64.7%
0.00%0.0%
Q3 2018$368,000
-35.9%
83,565
+4.9%
0.00%0.0%
Q2 2018$574,000
+319.0%
79,692
+129.8%
0.00%
Q1 2017$137,000
-12.7%
34,686
+8.4%
0.00%
Q4 2016$157,000
-32.9%
32,000
+5.7%
0.00%
-100.0%
Q3 2016$234,000
+39.3%
30,275
+1.0%
0.00%
Q2 2016$168,000
+6.3%
29,975
+2.0%
0.00%
Q1 2016$158,000
-37.8%
29,400
+0.8%
0.00%
-100.0%
Q4 2015$254,000
+21.0%
29,170
+16.4%
0.00%0.0%
Q3 2015$210,000
-50.2%
25,060
+4.6%
0.00%0.0%
Q2 2015$422,00023,9500.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders